New Liver Cancer Findings from Tianjin Medical University Cancer Institute and Hospital Described (Sorafenib Combined With Tace Improves Survival In Patients With Hepatocellular Carcinoma With Vascular Invasion)

Media coverage

• Title	New Liver Cancer Findings from Tianjin Medical University Cancer Institute and Hospital Described (Sorafenib Combined With Tace Improves Survival In Patients With Hepatocellular Carcinoma With Vascular Invasion)
  Media name/outlet	Cancer Daily
  Country/Territory	United States
  Date	11/15/24
  Persons	Lu Chen